A rating of 74 puts Aridis Pharmaceuticals Inc (ARDS) near the top of the Biotechnology industry according to InvestorsObserver. Aridis Pharmaceuticals Inc's score of 74 means it scores higher than 74% of stocks in the industry. Aridis Pharmaceuticals Inc also received an overall rating of 56, putting it above 56% of all stocks. Biotechnology is ranked 66 out of the 148 industries.
ARDS has an Overall Score of 56. Find out what this means to you and get the rest of the rankings on ARDS!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Aridis Pharmaceuticals Inc Stock Today?
Aridis Pharmaceuticals Inc (ARDS) stock is down -2.28% while the S&P 500 is up 0.13% as of 12:30 PM on Friday, Jun 17. ARDS has fallen -$0.04 from the previous closing price of $1.59 on volume of 40,395 shares. Over the past year the S&P 500 has fallen -13.03% while ARDS has fallen -77.17%. ARDS lost -$3.44 per share the over the last 12 months.
Click Here to get the full Stock Report for Aridis Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
